Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain, Postoperative

In brief

A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.

Key facts

Study ID

NCT00375934

Run by

Xanodyne Pharmaceuticals

People needed

200

Starts

2006-09-01

Last updated by the study team

2010-09-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years of age
• Have undergone bunionectomy surgery
• Have achieved adequate post-surgical pain

You may not qualify if…

• Confounding medical conditions which preclude study participation
• Participated in a study of another investigational drug or device within 30 days prior to randomization

Where it is running

• Investigative Site — Austin, Texas, United States
• Investigative Site — Houston, Texas, United States
• Investigative Site — San Marcos, Texas, United States
• Investigative Site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.